Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
Holders of 5% or more of KZR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kezar Life Sciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Equal Talent Investments Ltd | 13D/A | 8.66%616.5K shares | – | Mar 3, 20251 filing | Mar 3, 2025 | SEC |
| Morningside Venture Investments Ltd | 13D/A | 8.45%616.5K shares | – | Feb 16, 20213 filings | Jan 16, 2025 | SEC |
| Avidity Partners Management LP | 13G/A | 6.90%502.6K shares | – | Jan 3, 20224 filings | Feb 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
51 Schedule 13D and 13G filings on Kezar Life Sciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 28, 20265:32 PM ET | Baselake Partners, LPand 2 others | 13G/A | 0.00%0 shares | 0.00 ppfrom 0.00%Below 5% | May 11, 2026 | SEC |
| May 13, 20264:15 PM ET | Tang Capital Management LLCand 6 others | 13D/A | 0.00%0 shares | −9.00 ppfrom 9.00%Below 5% | May 11, 2026 | SEC |
| May 12, 20265:17 PM ET | Baselake Partners, LPand 2 others | 13G/A | 0.00%391.9K shares | −5.30 ppfrom 5.30%Below 5% | May 11, 2026 | SEC |
| May 12, 20264:44 PM ET | BML Investment Partners, L.P. | 13G/A | 0.00%0 shares | −9.80 ppfrom 9.80%Below 5% | May 11, 2026 | SEC |
| Apr 6, 20269:28 PM ET | Baselake Partners, LPand 2 others | 13G | 5.30%391.9K shares | New | Mar 30, 2026 | SEC |
| Apr 1, 20264:14 PM ET | Tang Capital Management LLCand 6 others | 13D/A | 9.00%664.3K shares | – | Mar 30, 2026 | SEC |
| Feb 13, 20265:00 PM ET | Stonepine Capital Management, LLCand 3 others | 13G/A | 2.10%156.2K shares | −3.10 ppfrom 5.20%Below 5% | Dec 31, 2025 | SEC |
| Feb 9, 20262:39 PM ET | BML Investment Partners, L.P. | 13G/A | 9.80%720.8K shares | +4.70 ppfrom 5.10% | Dec 31, 2025 | SEC |
| Nov 14, 20251:33 PM ET | Avidity Partners Management LPand 5 others | 13G/A | 0.00%0 shares | –Below 5% | Sep 30, 2025 | SEC |
| Sep 8, 20255:44 PM ET | Stonepine Capital Management, LLCand 3 others | 13G | 5.20%377.2K shares | New | Sep 2, 2025 | SEC |
| Mar 21, 20255:54 PM ET | Barclays PLC | 13G/A | – | – | Sep 30, 2024 | SEC |
| Mar 6, 20255:46 PM ET | BML Investment Partners, L.P. | 13G | 5.10%368.6K shares | New | Feb 28, 2025 | SEC |
| Mar 3, 20254:01 PM ET | Equal Talent Investments Ltdand 1 other | 13D/A | 8.66%616.5K shares | – | Feb 28, 2025 | SEC |
| Feb 14, 202510:42 AM ET | Avidity Partners Management LPand 6 others | 13G/A | 6.90%502.6K shares | – | Dec 31, 2024 | SEC |
| Jan 16, 20256:33 PM ET | Morningside Venture Investments Ltdand 6 others | 13D/A | 8.45%616.5K shares | – | Dec 3, 2024 | SEC |
| Nov 14, 202412:24 PM ET | Barclays PLC | 13G/A | – | – | Sep 30, 2024 | SEC |
| Oct 8, 2024 | Tang Capital Management LLC | 13DOld format | – | New | – | SEC |
| Jul 8, 20244:32 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Avidity Partners Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Barclays PLC | 13GOld format | – | New | – | SEC |
| Feb 13, 2024 | Prosight Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Suvretta Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20243:26 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 23, 2024 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Jan 22, 2024 | Millennium Management LLC | 13G/AOld format | – | – | – | SEC |
| Aug 17, 2023 | Morningside Venture Investments Ltd | 13D/AOld format | – | – | – | SEC |
| Jun 21, 2023 | Millennium Management LLC | 13GOld format | – | – | – | SEC |
| Apr 21, 2023 | Prosight Management, LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | OrbiMed Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Avidity Partners Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Suvretta Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20234:27 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 3, 2023 | State Street Corp | 13GOld format | – | New | – | SEC |
| Jan 31, 2023 | Franklin Resources Inc | 13G/AOld format | – | – | – | SEC |
| Jan 17, 2023 | Millennium Management LLC | 13G/AOld format | – | – | – | SEC |
| Jun 23, 2022 | Millennium Management LLC | 13GOld format | – | New | – | SEC |
| Jun 13, 2022 | Suvretta Capital Management, LLC | 13GOld format | – | New | – | SEC |
| May 9, 20223:23 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 14, 2022 | Logos Global Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | Franklin Resources Inc | 13GOld format | – | New | – | SEC |
| Feb 3, 20224:41 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 3, 2022 | Avidity Partners Management LP | 13GOld format | – | New | – | SEC |
| Jul 29, 2021 | Logos Global Management LP | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Morningside Venture Investments Ltd | 13D/AOld format | – | – | – | SEC |
| Feb 12, 2021 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Kezar Life Sciences, Inc. shares.
No Form 144 notices for Kezar Life Sciences, Inc. are on file.